<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="3" ids="44915">Propofol</z:chebi> (2,6-diisopropylphenol) has been shown to attenuate neuronal injury in a number of experimental conditions, but studies in models of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> have yielded conflicting results </plain></SENT>
<SENT sid="1" pm="."><plain>Moreover, the mechanisms involved in its neuroprotective effects are yet unclear </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The authors evaluated the neuroprotective effects of <z:chebi fb="3" ids="44915">propofol</z:chebi> in rat organotypic hippocampal slices exposed to oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation, an in vitro model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>To investigate its possible mechanism of action, the authors then examined whether <z:chebi fb="3" ids="44915">propofol</z:chebi> could reduce <z:chebi fb="0" ids="29108">Ca2+</z:chebi>-induced rat brain <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> swelling, an index of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane permeability, as well as the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> swelling evoked by oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation in CA1 pyramidal cells by transmission electron microscopy </plain></SENT>
<SENT sid="4" pm="."><plain>Finally, they evaluated whether <z:chebi fb="3" ids="44915">propofol</z:chebi> could attenuate the <z:mpath ids='MPATH_124'>infarct</z:mpath> size and improve the neurobehavioral outcome in rats subjected to permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: When present in the incubation medium during oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation and the subsequent 24 h recovery period, <z:chebi fb="3" ids="44915">propofol</z:chebi> (10-100 microM) attenuated CA1 injury in hippocampal slices in vitro </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="29108">Ca2+</z:chebi>-induced brain <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> swelling was prevented by 30-100 microM <z:chebi fb="3" ids="44915">propofol</z:chebi>, and so were the ultrastructural <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> changes in CA1 pyramidal cells exposed to oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty-four hours after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, <z:chebi fb="3" ids="44915">propofol</z:chebi> (100 mg/kg, intraperitoneal) reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size by approximately 30% when administered immediately after and up to 30 min after the occlusion </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, <z:chebi fb="3" ids="44915">propofol</z:chebi> administered within 30 min after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was unable to affect the global neurobehavioral score but significantly preserved spontaneous activity in ischemic rats </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These results show that <z:chebi fb="3" ids="44915">propofol</z:chebi>, at clinically relevant concentrations, is neuroprotective in models of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in vitro and in vivo and that it may act by preventing the increase in neuronal <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> swelling </plain></SENT>
</text></document>